Implantation of carmustine wafers (Gliadel®) for high-grade glioma treatment. A 9-year nationwide retrospective study

Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma

(2019) Sotirios Katsigiannis et al.   Radiation Oncology

Long-Term Survival After Decompressive Craniectomy for Malignant Brain Infarction: A 10-Year Nationwide Study

(2019) Charles Champeaux et al.   Neurocritical Care

Association of patterns of care, prognostic factors, and use of radiotherapy–temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study

(2018) Pascale Fabbro-Peray et al.   JOURNAL OF NEURO-ONCOLOGY

Epidemiology of meningiomas. A nationwide study of surgically treated tumours on French medico-administrative data

(2018) Charles Champeaux et al.   Cancer Epidemiology

Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit

(2017) William Sage et al.   JOURNAL OF NEURO-ONCOLOGY

Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice

(2017) Alexandre Roux et al.   JOURNAL OF NEURO-ONCOLOGY

Carmustine wafer implantation for high-grade gliomas: Evidence-based safety efficacy and practical recommendations from the Neuro-oncology Club of the French Society of Neurosurgery

(2017) A. Roux et al.   NEUROCHIRURGIE

Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review

(2016) Lynn S. Ashby et al.   World Journal of Surgical Oncology

Basic statistical reporting for articles published in Biomedical Journals: The “Statistical Analyses and Methods in the Published Literature” or the SAMPL Guidelines

(2015) Thomas A. Lang et al.   INTERNATIONAL JOURNAL OF NURSING STUDIES

Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis

(2015) Sajeel A. Chowdhary et al.   JOURNAL OF NEURO-ONCOLOGY

Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma

(2015) Matthew Z. Sun et al.   JOURNAL OF NEUROSURGERY

Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort

(2015) Johan Pallud et al.   NEURO-ONCOLOGY

Risk of surgical site infection in 401 consecutive patients with glioblastoma with and without carmustine wafer implantation

(2015) Kaisorn L. Chaichana et al.   NEUROLOGICAL RESEARCH

The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis

(2015) Zhen-yu Qi et al.   Drug Design Development and Therapy

The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines

(2015) Stuart G. Nicholls et al.   PLoS One

Implanted Carmustine Wafers Followed by Concomitant Radiochemotherapy to Treat Newly Diagnosed Malignant Gliomas: Prospective, Observational, Multicenter Study on 92 Cases

(2012) Julien Duntze et al.   ANNALS OF SURGICAL ONCOLOGY

The effects of the NICE Technology Appraisal 121 (Gliadel and Temozolomide) on survival in high-grade glioma

(2012) James Geoffrey Barr et al.   BRITISH JOURNAL OF NEUROSURGERY

NICE guidance on the use of carmustine wafers in high grade gliomas: a national study on variation in practice

(2012) Stephen J. Price et al.   BRITISH JOURNAL OF NEUROSURGERY

O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy w

(2012) Emmanuèle Lechapt-Zalcman et al.   CANCER

Improved survival time trends for glioblastoma using the SEER 17 population-based registries

(2011) Matthew Koshy et al.   JOURNAL OF NEURO-ONCOLOGY

Biodegradable Carmustine Wafers (Gliadel) Alone or in Combination with Chemoradiotherapy: The French Experience

(2010) Philippe Menei et al.   ANNALS OF SURGICAL ONCOLOGY

Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004

(2010) L. Bauchet et al.   NEURO-ONCOLOGY

Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation

(2009) Philippe Metellus et al.   CANCER